Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Video

Updated: Jun 12, 2026

Establishment and Characterization of Small Bowel Neuroendocrine Tumor Spheroids
09:43

Establishment and Characterization of Small Bowel Neuroendocrine Tumor Spheroids

Published on: October 14, 2019

[Small bowel adenocarcinoma].

A Zaanan1, P Afchain, N Carrere

  • 1Service d'oncologie médicale, hôpital Saint-Antoine, Paris, France. aziz.zaanan@gmail.com

Gastroenterologie Clinique Et Biologique
|June 12, 2010
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

Inflammatory Bowel Disease V: Surgical Management01:21

Inflammatory Bowel Disease V: Surgical Management

Surgical interventions for inflammatory bowel disease (IBD), which includes ulcerative colitis and Crohn's disease, are essential in managing symptoms and addressing complications. The selection of surgical procedures is contingent upon the specific conditions and complications that stem from these illnesses.
Here are some common surgical interventions for IBD:

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Checkpoint inhibitors in microsatellite instability-high metastatic colorectal cancer: treatment strategies, specificities, and care management questions.

ESMO gastrointestinal oncology·2026
Same author

Clinical impact of circulating tumor DNA to track minimal residual disease in colorectal cancer patients. Hopes and limitations.

ESMO gastrointestinal oncology·2026
Same author

ASO Visual Abstract: Does Splenic Hilar Lymph Node Harvesting Impact Outcomes following Total Gastrectomy for Cancer? A Multi-Institutional Retrospective Study with Propensity Score Matching.

Annals of surgical oncology·2025
Same author

Does Splenic Hilar Lymph Node Harvesting Impact Outcomes After Total Gastrectomy for Cancer? A Multi-Institutional Retrospective Study With Propensity Score-Matching.

Annals of surgical oncology·2025
Same author

Regorafenib combined with irinotecan as second-line treatment in metastatic gastro-oesophageal adenocarcinomas: results of PRODIGE 58-UCGI35-REGIRI Unicancer randomised phase II study.

ESMO open·2025
Same author

Promoting large multinational academic clinical trials for gastrointestinal cancers in Europe: the ENGIC (European Network for GI Cancers) initiative.

ESMO open·2025
Same journal

[Not Available].

Gastroenterologie clinique et biologique·2014
Same journal

[Not Available].

Gastroenterologie clinique et biologique·2014
Same journal

[Not Available].

Gastroenterologie clinique et biologique·2014
Same journal

[Not Available].

Gastroenterologie clinique et biologique·2014
Same journal

[Not Available].

Gastroenterologie clinique et biologique·2014
Same journal

[Not Available].

Gastroenterologie clinique et biologique·2014
See all related articles

Small bowel adenocarcinoma is a rare cancer often diagnosed late. Early detection and surgical resection are key, while chemotherapy effectiveness is under investigation.

Area of Science:

  • Gastroenterology and Oncology
  • Surgical Oncology
  • Medical Oncology

Context:

  • Small bowel adenocarcinoma (SBA) is a rare gastrointestinal malignancy.
  • Often diagnosed at advanced stages due to nonspecific symptoms.
  • Predisposing factors include Crohn disease, genetic syndromes, and celiac disease.

Purpose:

  • To review current diagnostic and treatment strategies for small bowel adenocarcinoma.
  • To highlight the importance of early diagnosis and surgical intervention.
  • To discuss the role and efficacy of chemotherapy in SBA management.

Summary:

  • Surgical resection is the primary curative option for non-metastatic SBA.
  • Lymph node status is a critical prognostic factor.
  • 5-fluorouracil and platinum-based chemotherapy show promise for metastatic disease, with FOLFOX under evaluation in a national cohort study.

Related Experiment Videos

Last Updated: Jun 12, 2026

Establishment and Characterization of Small Bowel Neuroendocrine Tumor Spheroids
09:43

Establishment and Characterization of Small Bowel Neuroendocrine Tumor Spheroids

Published on: October 14, 2019

Impact:

  • Improved diagnostic methods may lead to earlier detection.
  • Further research on adjuvant and palliative chemotherapy is crucial.
  • Standardization of treatment protocols can enhance patient outcomes for this rare cancer.